Joseph A. Sinkule
About
In The Last Decade
Joseph A. Sinkule
14 papers receiving 468 citations
Peers
Comparison fields: 5 of 75
- Oncology 276
- Molecular Biology 242
- Epidemiology 69
- Cardiology and Cardiovascular Medicine 63
- Pediatrics, Perinatology and Child Health 51
Countries citing papers authored by Joseph A. Sinkule
This map shows the geographic impact of Joseph A. Sinkule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph A. Sinkule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph A. Sinkule more than expected).
Fields of papers citing papers by Joseph A. Sinkule
This network shows the impact of papers produced by Joseph A. Sinkule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph A. Sinkule. The network helps show where Joseph A. Sinkule may publish in the future.
Co-authorship network of co-authors of Joseph A. Sinkule
This figure shows the co-authorship network connecting the top 25 collaborators of Joseph A. Sinkule. A scholar is included among the top collaborators of Joseph A. Sinkule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joseph A. Sinkule. Joseph A. Sinkule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 11 | |
| 2 | 28 | |
| 3 | 76 | |
| 4 | 26 | |
| 5 | 32 | |
| 6 | Phase I clinical and pharmacological study of 72-hour continuous infusion of etoposide in patients with advanced cancer. | 72 |
| 7 | 7 | |
| 8 | 12 | |
| 9 | Teniposide (VM26) disposition in children with leukemia. | 21 |
| 10 | 61 | |
| 11 | 81 | |
| 12 | 21 | |
| 13 | 16 | |
| 14 | 25 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.